ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

Federal Hospitals Should Share Radiotherapy Facilitates: GAO

February 16, 1979

ImClone: Waksals To Pay $5 Million To Settle With SEC.

January 28, 2005

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010

NIH Study Sections Use New Scoring Procedure

July 3, 1998

NCA Approves Major Revision In Program Project Guidelines; Smaller, Tightly Focused Grants Seen

May 27, 1983

Cedars-Sinai Develops Criteria For FDG-PET In Breast Cancer

August 25, 2006